| Q35015449 | Clinical features and multidisciplinary approaches to dementia care |
| Q37389846 | Combining cognitive screening tests for the evaluation of mild cognitive impairment in the elderly. |
| Q33777509 | Diagnosis and biomarkers of predementia in Alzheimer's disease. |
| Q51135677 | Diagnostic transitions in mild cognitive impairment subtypes. |
| Q41549656 | Neuropsychiatric symptoms and faster progression of cognitive impairments as predictors of risk of conversion of mild cognitive impairment to dementia |
| Q36034307 | Predicting Alzheimer's disease: neuropsychological tests, self-reports, and informant reports of cognitive difficulties |
| Q51782041 | Profiles of functional deficits in mild cognitive impairment and dementia: benefits from objective measurement. |
| Q36002365 | Should mild cognitive impairment be subtyped? |
| Q44292423 | To treat or not to treat? A meta-analysis of the use of cholinesterase inhibitors in mild cognitive impairment for delaying progression to Alzheimer's disease |